Ha habido 50 transacciones internas recientes registradas para Larimar Therapeutics, Inc. (LRMR), incluyendo 47 compras y 0 ventas. El total de compras internas fue valorado en $34.99M y el total de ventas internas en RSU Award.
Internos destacados con actividad reciente incluyen Sherman Jeffrey W, Thomas Frank E, Flynn James E. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — LRMR
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-02-27 |
Sherman Jeffrey W |
Director |
Compra Informativa |
5,000 |
$5.00 |
$25K |
5,000 |
| 2026-02-27 |
Thomas Frank E |
Director |
Compra Informativa |
5,000 |
$5.00 |
$25K |
7,000 |
| 2026-02-27 |
Flynn James E |
10 Percent Owner, Other: * Director By Deputization |
Compra Informativa |
2,000,000 |
$5.00 |
$10M |
6,207,982 |
| 2026-02-27 |
Hamilton Thomas Edward |
Director |
Compra Informativa |
100,000 |
$5.00 |
$500K |
664,798 |
| 2026-01-26 |
Celano Michael |
Chief Financial Officer |
Concesión de RSU |
37,604 |
- |
- |
215,785 |
| 2026-01-26 |
Ben-maimon Carole |
President and CEO |
Concesión de RSU |
100,100 |
- |
- |
368,276 |
| 2026-01-26 |
Clayton Russell |
Chief Medical Officer |
Concesión de RSU |
25,637 |
- |
- |
71,443 |
| 2026-01-26 |
Shankar Gopi |
Chief Development Officer |
Concesión de RSU |
25,637 |
- |
- |
76,443 |
| 2025-07-31 |
Flynn James E |
10 Percent Owner, Other: * Director By Deputization |
Compra Informativa |
2,599,932 |
$3.20 |
$8.32M |
7,321,129 |
| 2025-05-13 |
Leff Jonathan S |
Director |
Concesión de RSU |
19,000 |
$1.88 |
$35.63K |
19,000 |
| 2025-05-13 |
Sherman Jeffrey W |
Director |
Concesión de RSU |
19,000 |
$1.88 |
$35.63K |
19,000 |
| 2025-05-13 |
Thomas Frank E |
Director |
Concesión de RSU |
19,000 |
$1.88 |
$35.63K |
19,000 |
| 2025-05-13 |
Truitt Joseph |
Director |
Concesión de RSU |
19,000 |
$1.88 |
$35.63K |
19,000 |
| 2025-05-13 |
Hamilton Thomas Edward |
Director |
Concesión de RSU |
19,000 |
$1.88 |
$35.63K |
19,000 |
| 2025-05-13 |
Flynn James E |
10 Percent Owner, Other: * Director By Deputization |
Concesión de RSU |
19,000 |
$1.88 |
$35.63K |
19,000 |
| 2025-01-22 |
Celano Michael |
Chief Financial Officer |
Concesión de RSU |
34,185 |
- |
- |
178,181 |
| 2025-01-22 |
Ben-maimon Carole |
President and CEO |
Concesión de RSU |
91,000 |
- |
- |
387,208 |
| 2025-01-22 |
Clayton Russell |
Chief Medical Officer |
Concesión de RSU |
23,306 |
- |
- |
45,806 |
| 2025-01-22 |
Shankar Gopi |
Chief Development Officer |
Concesión de RSU |
23,306 |
- |
- |
50,806 |
| 2024-05-29 |
Leff Jonathan S |
Director |
Concesión de RSU |
19,000 |
$7.07 |
$134.33K |
19,000 |
| 2024-05-29 |
Sherman Jeffrey W |
Director |
Concesión de RSU |
19,000 |
$7.07 |
$134.33K |
19,000 |
| 2024-05-29 |
Thomas Frank E |
Director |
Concesión de RSU |
19,000 |
$7.07 |
$134.33K |
19,000 |
| 2024-05-29 |
Truitt Joseph |
Director |
Concesión de RSU |
19,000 |
$7.07 |
$134.33K |
19,000 |
| 2024-05-29 |
Hamilton Thomas Edward |
Director |
Concesión de RSU |
19,000 |
$7.07 |
$134.33K |
19,000 |
| 2024-05-29 |
Flynn James E |
10 Percent Owner, Other: * Director By Deputization |
Concesión de RSU |
19,000 |
$7.07 |
$134.33K |
19,000 |
| 2024-02-16 |
Flynn James E |
10 Percent Owner, Other: * Director By Deputization |
Compra Informativa |
1,430,205 |
$8.74 |
$12.5M |
4,207,982 |
| 2024-02-16 |
Hamilton Thomas Edward |
Director |
Compra Informativa |
57,208 |
$8.74 |
$500K |
564,798 |
| 2024-02-14 |
Thomas Frank E |
Director |
Compra Informativa |
2,000 |
$11.00 |
$22K |
2,000 |
| 2024-01-17 |
Celano Michael |
Chief Financial Officer |
Concesión de RSU |
31,250 |
- |
- |
143,996 |
| 2024-01-17 |
Ben-maimon Carole |
President and CEO |
Concesión de RSU |
66,125 |
- |
- |
332,954 |
| 2024-01-17 |
Clayton Russell |
Chief Medical Officer |
Concesión de RSU |
22,500 |
- |
- |
22,500 |
| 2024-01-17 |
Shankar Gopi |
Chief Development Officer |
Concesión de RSU |
22,500 |
- |
- |
27,500 |
| 2023-12-07 |
Shankar Gopi |
Chief Development Officer |
Compra Informativa |
5,000 |
$3.73 |
$18.66K |
5,000 |
| 2023-10-03 |
Sherman Jeffrey W |
Director |
Desconocido |
- |
- |
- |
- |
| 2023-10-03 |
Sherman Jeffrey W |
Director |
Concesión de RSU |
16,600 |
$3.56 |
$59.01K |
16,600 |
| 2023-07-17 |
Clayton Russell |
Officer |
Desconocido |
- |
- |
- |
- |
| 2023-07-17 |
Clayton Russell |
Chief Medical Officer |
Concesión de RSU |
180,000 |
$3.22 |
$579.6K |
180,000 |
| 2023-05-17 |
Celano Michael |
Chief Financial Officer |
Compra Informativa |
5,000 |
$3.73 |
$18.63K |
112,746 |
| 2023-05-17 |
Truitt Joseph |
Director |
Compra Informativa |
2,750 |
$3.73 |
$10.26K |
2,750 |
| 2023-05-17 |
Ben-maimon Carole |
President and CEO |
Compra Informativa |
5,000 |
$3.71 |
$18.53K |
266,829 |
| 2023-05-09 |
Leff Jonathan S |
Director |
Concesión de RSU |
8,300 |
$5.09 |
$42.25K |
8,300 |
| 2023-05-09 |
Thomas Frank E |
Director |
Concesión de RSU |
8,300 |
$5.09 |
$42.25K |
8,300 |
| 2023-05-09 |
Flynn James E |
10 Percent Owner |
Concesión de RSU |
8,300 |
$5.09 |
$42.25K |
8,300 |
| 2023-05-09 |
Truitt Joseph |
Director |
Concesión de RSU |
8,300 |
$5.09 |
$42.25K |
8,300 |
| 2023-05-09 |
Hamilton Thomas Edward |
Director |
Concesión de RSU |
8,300 |
$5.09 |
$42.25K |
8,300 |
| 2023-02-07 |
Shankar Gopi |
Officer |
Desconocido |
- |
- |
- |
- |
| 2023-02-07 |
Shankar Gopi |
Chief Development Officer |
Concesión de RSU |
180,000 |
$5.88 |
$1.06M |
180,000 |
| 2023-01-31 |
Celano Michael |
Chief Financial Officer |
Concesión de RSU |
76,000 |
- |
- |
107,746 |
| 2023-01-31 |
Ben-maimon Carole |
President and CEO |
Concesión de RSU |
205,000 |
- |
- |
261,829 |
| 2022-09-16 |
Celano Michael |
Chief Financial Officer |
Compra Informativa |
31,746 |
$3.15 |
$100K |
31,746 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
